companies

Selfapy

Founded 2016
Employees 100+
Primary contact
Kastanienallee 29/30
10435 Berlin
Germany
+49 (0) 30 3982031 20
Links
https://www.selfapy.com/
Sections
Selfapy has developed a digital therapeutics platform addressing multiple mental health disorders. It provides online self-help courses for patients with depression and anxiety disorders, as well as binge-eating disorder and bulimia. The digital treatments have been approved by Germany for reimbursement under all statutory health insurance policies. All Selfapy treatments use cognitive behavioral therapy (CBT), and the platform has been listed in Germany's federal medical device directory.
Founded 2016
Employees 100+
Primary contact
Kastanienallee 29/30
10435 Berlin
Germany
+49 (0) 30 3982031 20
Links
https://www.selfapy.com/
Sections

Funding 💰

Total €13M
Last round 🔗 €7M
Other
February 17, 2023.
Select investors SHS Capital, Medice Arzneimittel, Think.Health, Mavericks Founders, Digital Health Ventures, High-Tech Grunderfonds (HTGF), IBB Ventures, Bryan, Garnier & Co., about:seed

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Big addressable market: It is thought that around 18 million German residents experience a mental illness, with wait lists for support lasting as long as six months.
  • Scientifically based: Selfapy's courses are at the cutting edge of research and are continuously examined by independent scientists in clinical studies. For instance, the Charité Berlin study on the Selfapy online course for depression shows a 39.5% reduction in symptoms and offers effective help for moderate depression. 🔗
  • Destigmatization of mental stress: Mental health affects us all. Selfapy raises awareness of the issue and works to destigmatize mental illness.
  • Media love: Selfapi has so far been well received in the media, with a few prominent outlets giving it some space, including Der Tagesspiegel, AerzteZeitung, Frankfurter Allgemeine Zeitung, and Süddeutsche Zeitung. 🔗

Video ▶️

Last update: March 7, 2023